Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 6/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | PPARG | P37231 | 1/20 | 0.40 |
| ▸ | PPARA | Q07869 | 1/20 | 0.40 |
| ▸ | RXFP1 | Q9HBX9 | 4/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL123529 | 1.00 | HIF1A (0.52) | HIF1AMEN1KMT2AGAAPPARG | |
| SCHEMBL30354029 | 1.00 | HIF1A (0.52) | HIF1AMEN1KMT2AGAAPPARG | |
| SCHEMBL123530 | 1.00 | HIF1A (0.52) | HIF1AMEN1KMT2AGAAPPARG | |
| SCHEMBL29765420 | 1.00 | HIF1A (0.52) | HIF1AMEN1KMT2AGAAPPARG | |
| SCHEMBL14141835 | 1.00 | HIF1A (0.52) | HIF1AMEN1KMT2AGAAPPARG | |
| SCHEMBL828172 | 1.00 | HIF1A (0.52) | HIF1AMEN1KMT2AGAAPPARG | |
| SCHEMBL30158137 | 0.92 | MEN1 (0.45) | HIF1AMEN1KMT2AGAAPPARG | |
| SCHEMBL13278820 | 0.92 | MEN1 (0.45) | HIF1AMEN1KMT2AGAAPPARG | |
| SCHEMBL168688 | 0.92 | MEN1 (0.45) | HIF1AMEN1KMT2AGAAPPARG | |
| SCHEMBL168689 | 0.92 | MEN1 (0.45) | HIF1AMEN1KMT2AGAAPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090280981-A1 | SYNERGISTIC ACTIVE INGREDIENT COMBINATIONS | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2009-11-12 | — | — | US | claimed |
| WO-2016055096-A1 | METHOD FOR TREATING RICE SEED | BAYER CROPSCIENCE AG (DE) | 2016-04-14 | — | — | WO | disclosed |
| EP-2699093-A1 | ACTIVE COMPOUND COMBINATIONS COMPRISING A (THIO)CARBOXAMIDE DERIVATIVE AND A FUNGICIDAL COMPOUND | Bayer Intellectual Property GmbH (DE) | 2014-02-26 | — | — | EP | disclosed |
| WO-2012143127-A1 | ACTIVE COMPOUND COMBINATIONS COMPRISING A (THIO)CARBOXAMIDE DERIVATIVE AND A FUNGICIDAL COMPOUND | BAYER CROPSCIENCES AG (DE) | 2012-10-26 | — | — | WO | disclosed |
| EP-2443090-A1 | SUBSTITUTED ENAMINO CARBONYL COMPOUNDS | Bayer Cropscience AG (DE) | 2012-04-25 | — | — | EP | disclosed |
| EP-2410850-A2 | SYNERGISTIC COMBINATIONS OF ACTIVE INGREDIENTS | Bayer Cropscience AG (DE) | 2012-02-01 | — | — | EP | disclosed |
| WO-2010145764-A1 | SUBSTITUTED ENAMINO CARBONYL COMPOUNDS | BAYER CROPSCIENCE AG (DE) | 2010-12-23 | — | — | WO | disclosed |
| WO-2010108507-A2 | SYNERGISTIC COMBINATIONS OF ACTIVE INGREDIENTS | BAYER CROPSCIENCE AG (DE) | 2010-09-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090280981-A1 | SYNERGISTIC ACTIVE INGREDIENT COMBINATIONS | CYP51A1, ERG28, CYP4X1 | HIF1A 4728/4885MEN1 2860/4885KMT2A 2897/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.